Liso-cel

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Liso-cel

Dec 17, 2024, 01:10 | Science

Hung Trinh: Optimizing the post-CAR T monitoring period in recipients of Axi-cel, Tisa-cel, and Liso-cel by Nausheen Ahmed et al.

A recent paper by Nausheen Ahmed, Medical Director of BMT Survivorship Program at The University…

Dec 11, 2024, 09:53 | Blog

Liso-cel is a feasible and effective option for patients with R/R large B cell lymphoma - MD Anderson Cancer Center

MD Anderson Cancer Center shared a post on X: “For patients with relapsed or refractory…

Nov 14, 2024, 12:33 | Insight

Ajay Major: Liso-cel in DLBCL with secondary CNS diagnosis by Jennifer Crombie

Ajay Major, Assistant Professor of Medicine at the University of Colorado School of Medicine, shared…

Jul 8, 2024, 17:31 | Insight

Kai Rejeski: Underestimated aspect of CAR T-cell therapy: non-relapse mortality

Kai Rejeski, Visiting investigator at Memorial Sloan Kettering Cancer Center, shared on X: “Hot off…

Jan 14, 2024, 17:49 | Insight

Amar Kelkar: We show Axi-cel and Liso-cel are NOT COST-EFFECTIVE in our decision analysis of second-line CAR-T therapies for Diffuse Large B-Cell Lymphoma

Amar Kelkar, Stem Cell Transplantation Physician at the Dana-Farber Cancer Institute, posted on X/Twitter: "Today in…

Dec 8, 2023, 12:40 | Insight

Amar Kelkar: We hope putting out independent cost-effectiveness analyses like this will encourage others to join

Amar Kelkar, Physician at the Dana-Farber Cancer Institute and an Instructor in Medicine at Harvard…

All: 6 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023